T3 and T4 true vocal cord squamous carcinomas treated with external beam irradiation: A single institution's 35-year experience

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 2, 2007, Pages 181-185

  Hinerman, Russell W ^a   Mendenhall, William M ^a   Morris, Christopher G ^a   Amdur, Robert J ^a   Werning, John W ^a   Villaret, Douglas B ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Radiotherapy; Squamous; Vocal cord

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DYSPHAGIA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GLOTTIS; HEART ARREST; HUMAN; INSTITUTIONAL REVIEW; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; NECROSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PUBLICATION; RADIATION DOSE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION;

CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; HUMANS; LARYNGEAL NEOPLASMS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VOCAL CORDS;

EID: 34147167715     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000251368.57302.cc     Document Type: Article

References (30)

1. Fleming ID, American Joint Committee on Cancer, American Cancer Society, American College of Surgeons. AJCC Cancer Staging Handbook From the AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven; 1998.
2. Parsons JT, Mendenhall WM, Stringer SP, et al. T4 laryngeal carcinoma: radiotherapy alone with surgery reserved for salvage. Int J Radiat Oncol Biol Phys. 1998;40:549-552.
3. Mendenhall WM, Parsons JT, Mancuso AA, et al. Definitive radiotherapy for T3 squamous cell carcinoma of the glottic larynx. J Clin Oncol. 1997;15:2394-2402.
4. Mendenhall WM, Parsons JT, Stringer SP, et al. Stage T3 squamous cell carcinoma of the glottic larynx: a comparison of laryngectomy and irradiation. Int J Radiat Oncol Biol Phys. 1992;23:725-732.
5. Parsons JT, Greene BD, Speer TW, et al. Treatment of early and moderately advanced vocal cord carcinoma with 6-MV x-rays. Int J Radiat Oncol Biol Phys. 2001;50:953-959.
6. Parsons JT, Mendenhall WM, Stringer SP, et al. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience. Head Neck. 1993;15:87-96.
7. Liauw SL, Mancuso AA, Amdur RJ. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol. 2006;24:1421-1427.
8. SAS OnlineDoc(r), version 9. Cary, NC: SAS Institute Inc; 2003.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
10. Cox DR. Regression models and life tables - series B (methodological). J R Stat Soc. 1972;34:187-220.
11. Pameijer FA, Mancuso AA, Mendenhall WM, et al. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys. 1997;37:1011-1021.
12. Foote RL, Olsen KD, Buskirk SJ, et al. Laryngectomy alone for T3 glottic cancer. Head Neck. 1994;16:406-412.
13. Mendenhall WM, Riggs CE, Amdur RJ, et al. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck. Laryngoscope. 2003;113:546-551.
14. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091-2098.
15. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med. 1991;324:1685-1690.
16. Garden AS. Is there still a role for induction chemotherapy for head and neck cancer? J Clin Oncol. 2005;23:1059-1060.
17. Nguyen-Tan PF, Le QT, Quivey JM, et al. Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys. 2001;50:1172-1180.
18. Harwood AR, Beale FA, Cummings BJ, et al. T3 glottic cancer: an analysis of dose-time-volume factors. Int J Radiat Oncol Biol Phys. 1980;6:675- 680.
19. Harwood AR, Beale FA, Cummings BJ, et al. T4N0M0 glottic cancer: an analysis of dose-time-volume factors. Int J Radiat Oncol Biol Phys. 1981;7:1507-1512.
20. Karim AB, Kralendonk JH, Njo KH, et al. Radiation therapy for advanced (T3T4N0-N3M0) laryngeal carcinoma: the need for a change of strategy: a radiotherapeutic viewpoint. Int J Radiat Oncol Biol Phys. 1987;13:1625-1633.
21. Sagerman RH, Chung CT, King GA, et al. High dose preoperative irradiation for advanced laryngeal- hypopharyngeal cancer. Ann Otol Rhinol Laryngol. 1979;88:178 -182.
22. MacKenzie RG, Franssen E, Balogh JM, et al. Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery. Int J Radiat Oncol Biol Phys. 2000;47:65-71.
23. Sessions DG, Lenox J, Spector GJ, et al. Management of T3N0M0 glottic carcinoma: therapeutic outcomes. Laryngoscope. 2002;112:1281-1288.
24. Spector GJ, Sessions DG, Lenox J, et al. Management of stage IV glottic carcinoma: therapeutic outcomes. Laryngoscope. 2004;114:1438-1446.
25. Fletcher GH, Lindberg RD, Jesse RH. Radiation therapy for cancer of the larynx and pyriform sinus. Eye Ear Nose Throat Digest. 1969;31:58-67.
26. Stewart JG, Brown JR, Palmer MK, et al. The management of glottic carcinoma by primary irradiation with surgery in reserve. Laryngoscope. 1975;85:1477-1484.
27. Skolyszewski J, Reinfuss M. The results of radiotherapy of cancer of the larynx in six European countries. Radiobiol Radiother (Berl). 1981;22:32-43.
28. Wang CC. Carcinoma of the larynx. In: Wang CC, ed. Radiation Therapy for Head and Neck Neoplasms, 3rd ed. New York: Wiley-Liss, Inc; 1997;221-255.
29. Bensadoun RJ, Benezery K, Dassonville O, et al. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: results at 2 years (FNCLCC-GORTEC). Int J Radiat Oncol Biol Phys. 2006;64:983-994.
30. Garden A, Harris J, Jones C, et al. Concomitant boost radiation and concurrent cisplatin for advanced head and neck carcinomas: update of a phase II trial of the RTOG (99-14). Int J Radiat Oncol Biol Phys. 2005;63(suppl 1):S71-S72.